Venture Capital Access Online | The eMarketplace for the Venture Capital Industry

 

Bookmark and Share   

Home

Marketplace
Database
Deals
News
Store
Resources
Contact Us

 

 

 

News

VCPro Database 2014 (17th Edition) Now Available! Newly released


Venture Capital Deals Spreadsheet Now Available Newly released


 

Medrobotics Closes $26 Million Series E Financing

Company Prepares for European Commercialization of the Ground-Breaking Flex® System in Otolaryngology

RAYNHAM, Mass., May 14, 2014-- Medrobotics Corp., a surgical products company with core competencies in medical robotics, announced today that it had closed its $26 Million Series E Preferred Stock financing. Existing Medrobotics shareholders and undisclosed new investors participated in the Series E raise. Proceeds will be used for regulatory preparations and submissions and for anticipated commercial launches in Europe and the United States.

The Company recently announced that it had received the CE mark for its Flex® System. "The Flex® System is the first robot-assisted flexible endoscopic platform for use during surgical procedures," said Samuel Straface, Ph.D., President and CEO of Medrobotics. “It extends the capability of surgeons to look and reach around corners and operate in hard-to-reach and confined spaces."

The Flex® System enables minimally invasive surgical procedures where conventional line-of-sight technologies are either not feasible or sub-optimal. Surgeons can navigate the Flex® Scope around anatomical structures to hard-to-reach locations through a single access site, and then use the onboard high-definition vision system to precisely deploy a range of proprietary and third party flexible surgical instruments. The uniquely “wristed” 3mm Flex® Instruments, which have also received the CE mark, enable the surgeon to further extend his or her reach to important and often challenging areas of the anatomy.

Minimally invasive surgery has demonstrated advantages for patients and providers compared to traditional open procedures, decreasing hospital stays and recovery times. The Flex® System was designed to provide a cost-effective, easy-to-use, and efficient robot-assisted surgical platform for hospitals and surgeons seeking to provide minimally-invasive treatment options to more patients.

About Medrobotics

Medrobotics Corporation (www.Medrobotics.com) is a privately-held company headquartered in Raynham, Massachusetts that is developing and commercializing the Flex® System, a robotic-assist platform that provides surgeons with single-site access and visualization of hard-to-reach anatomical locations. The Company’s vision is to provide more patients with access to minimally invasive surgery, and, having received the CE mark for its Flex® System, Medrobotics is preparing the commercial launch of its products in Europe. These products are not currently approved for sale in the U.S.

Contact:
Medrobotics Corporation
Diane Wilson, +1-978-656-1258


News Index

Venture Capital Database

Venture Capital Deals Spreadsheet

 

 NEWS

Latest VC News
VC News Archive
News Search
Venture Capital Deals New
RSS News Feed

List Your Firm

Entrepreneurs
Investors
Advisors

Venture Capital Database

VCPro Database
Download Trial
Buy Now

Venture Capital Deals

vcaDeals
Download Sample
Buy Now

VC Tools

Venture Capital StarterPak
VC Pitch
Private Placement Memorandum
Confidentiality Agreement Package
Series A Preferred Term Sheet
Bridge Financing Contract
Employment Agreements
Understanding Employee Stock Options

Business Plan Tools

Free Business Plan Template
Sample Business Plans
Business Plan Pro

 

 

Copyright © 1998-2014 Access InterComm  All rights reserved. 
Site Map | Privacy Statement | Legal Notice & Disclaimer